Rationalizing ADME in the Current Regulatory and Business Environment
Robert Guttendorf, Aclairo Pharmaceutical Development Group, speaking at ADME & Predictive Toxicology Europe
Fragment-Based Screening and Structure-Based Design at ICR: Discovering High Quality Leads in Cancer Drug Discovery
Rob Van Montfort, Institute of Cancer Research, speaking at Discovery Chemistry Conference 2012.
Improvement of Cell Culture Technology for Primary Cells and Stem Cell Manipulation
Dr Veit Bergendahl, Miltenyi Biotec GmbH, speaking at Cell Culture 2012
Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches
Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe
Analysis of Cellular Image-based RNAi Screens Beyond Human Vision
Professor Frederic Bard, Institute of Molecular and Cell Biology, speaking at Screening Asia 2011.
Functional Interrogation of 'omics' Data
Dr Kartiki V Desai, National Insitute of Biomedical Genomics, speaking at Screening Asia 2011.
Understanding Fat Metabolism at the Organism Level – A Comprehensive Metabolic Screen of C. elegans.
Dr Jules Griffin, University of Cambridge, speaking at Advances in Metabolic Profiling 2011.
Actionable Biomarkers for Rheumatoid Arthritis
Dr William Robinson, Stanford University, speaking at Microarray World Congress 2011.
The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain Pathologies
Professor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.